<?xml version='1.0' encoding='utf-8'?>
<graphml xmlns="http://graphml.graphdrawing.org/xmlns" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://graphml.graphdrawing.org/xmlns http://graphml.graphdrawing.org/xmlns/1.0/graphml.xsd"><key attr.name="id" attr.type="string" for="edge" id="d17"/>
<key attr.name="description" attr.type="string" for="edge" id="d16"/>
<key attr.name="interactionType" attr.type="string" for="edge" id="d15"/>
<key attr.name="entrezIds" attr.type="string" for="node" id="d14"/>
<key attr.name="uniprotIds" attr.type="string" for="node" id="d13"/>
<key attr.name="ensemblIds" attr.type="string" for="node" id="d12"/>
<key attr.name="label" attr.type="string" for="node" id="d11"/>
<key attr.name="y" attr.type="string" for="node" id="d10"/>
<key attr.name="x" attr.type="string" for="node" id="d9"/>
<key attr.name="description" attr.type="string" for="node" id="d8"/>
<key attr.name="type" attr.type="string" for="node" id="d7"/>
<key attr.name="nodeLabel" attr.type="string" for="node" id="d6"/>
<key attr.name="keggIds" attr.type="string" for="node" id="d5"/>
<key attr.name="url" attr.type="string" for="node" id="d4"/>
<key attr.name="nodeName" attr.type="string" for="node" id="d3"/>
<key attr.name="nodeColor" attr.type="string" for="node" id="d2"/>
<key attr.name="nodePosition" attr.type="string" for="node" id="d1"/>
<key attr.name="nodeSize" attr.type="string" for="node" id="d0"/>
<graph edgedefault="directed"><node id="n0">
  <data key="d0">233|25</data>
  <data key="d1">40|45</data>
  <data key="d2">#00FF00</data>
  <data key="d3">Graft-versus-host disease</data>
  <data key="d4">http://www.kegg.jp/dbget-bin/www_bget?hsa05332</data>
  <data key="d5">path:hsa05332</data>
  <data key="d6">Graft-versus-host disease - Homo sapiens (human)</data>
  <data key="d7">pathway</data>
  <data key="d8">Graft-versus-host disease (GVHD) is a lethal complication of allogeneic hematopoietic stem cell transplantation (HSCT) where immunocompetent donor T cells attack the genetically disparate host cells. GVHD pathophysiology can be summerized in a three-step process. Step 1 involves the development of an inflammatory milieu resulting from damage in the host tissues induced by the preparative chemotherapy or radiotherapy regimen. Damaged tissues secrete inflammatory cytokines including interleukin 1 (IL-1) and tumor necrosis factor (TNF-alpha ). During step 2 antigen-presenting cells (APCs) trigger the activation of donor-derived T cells which induce further T-cell expansion induce cytotoxic T lymphocytes (CTL) and natural killer (NK) cells responses and prime additional mononuclear phagocytes to produce TNF-alpha and IL-1. Also nitric oxide (NO) is produced by activated macrophages and it may contribute to the tissue damage seen during step 3. During step 3 the effector phase activated CTL and NK cells mediate cytotoxicity against target host cells through Fas-Fas ligand interactions and perforin-granzyme B.</data>
  <data key="d9">40.5</data>
  <data key="d10">45.5</data>
  <data key="d11">Graft-versus-host disease</data>
</node>
<node id="n1">
  <data key="d0">46|17</data>
  <data key="d1">1000|114</data>
  <data key="d2">#BFFFBF</data>
  <data key="d3">FAS</data>
  <data key="d4">http://www.kegg.jp/dbget-bin/www_bget?hsa:355</data>
  <data key="d12">ENSG00000026103</data>
  <data key="d13">P25445</data>
  <data key="d5">hsa:355</data>
  <data key="d14">355</data>
  <data key="d6">FAS ALPS1A APO-1 APT1 CD95 FAS1 FASTM TNFRSF6</data>
  <data key="d7">protein</data>
  <data key="d8">(RefSeq) Fas cell surface death receptor</data>
  <data key="d9">1000.0</data>
  <data key="d10">114.5</data>
  <data key="d11">FAS</data>
</node>
<node id="n2">
  <data key="d0">46|17</data>
  <data key="d1">923|114</data>
  <data key="d2">#BFFFBF</data>
  <data key="d3">FASLG</data>
  <data key="d4">http://www.kegg.jp/dbget-bin/www_bget?hsa:356</data>
  <data key="d12">ENSG00000117560</data>
  <data key="d13">P48023 Q53ZZ1</data>
  <data key="d5">hsa:356</data>
  <data key="d14">356</data>
  <data key="d6">FASLG ALPS1B APT1LG1 APTL CD178 CD95-L CD95L FASL TNFSF6 TNLG1A</data>
  <data key="d7">protein</data>
  <data key="d8">(RefSeq) Fas ligand</data>
  <data key="d9">923.0</data>
  <data key="d10">114.5</data>
  <data key="d11">FASLG</data>
</node>
<node id="n3">
  <data key="d0">46|17</data>
  <data key="d1">498|207</data>
  <data key="d2">#BFFFBF</data>
  <data key="d3">CD28</data>
  <data key="d4">http://www.kegg.jp/dbget-bin/www_bget?hsa:940</data>
  <data key="d12">ENSG00000178562</data>
  <data key="d13">P10747</data>
  <data key="d5">hsa:940</data>
  <data key="d14">940</data>
  <data key="d6">CD28 Tp44</data>
  <data key="d7">protein</data>
  <data key="d8">(RefSeq) CD28 molecule</data>
  <data key="d9">498.0</data>
  <data key="d10">207.5</data>
  <data key="d11">CD28</data>
</node>
<node id="n4">
  <data key="d0">46|17</data>
  <data key="d1">417|207</data>
  <data key="d2">#BFFFBF</data>
  <data key="d3">CD86</data>
  <data key="d4">http://www.kegg.jp/dbget-bin/www_bget?hsa:941+hsa:942</data>
  <data key="d12">ENSG00000121594,ENSG00000114013</data>
  <data key="d13">P33681 A0N0P2,P42081 A8K632</data>
  <data key="d5">hsa:941,hsa:942</data>
  <data key="d14">941,942</data>
  <data key="d6">CD80 B7 B7-1 B7.1 BB1 CD28LG CD28LG1 LAB7, CD86 B7-2 B7.2 B70 CD28LG2 LAB72</data>
  <data key="d7">protein</data>
  <data key="d8">(RefSeq) CD80 molecule,(RefSeq) CD86 molecule</data>
  <data key="d9">417.0</data>
  <data key="d10">207.5</data>
  <data key="d11">CD86</data>
</node>
<node id="n5">
  <data key="d0">46|17</data>
  <data key="d1">1000|278</data>
  <data key="d2">#BFFFBF</data>
  <data key="d3">FAS</data>
  <data key="d4">http://www.kegg.jp/dbget-bin/www_bget?hsa:355</data>
  <data key="d12">ENSG00000026103</data>
  <data key="d13">P25445</data>
  <data key="d5">hsa:355</data>
  <data key="d14">355</data>
  <data key="d6">FAS ALPS1A APO-1 APT1 CD95 FAS1 FASTM TNFRSF6</data>
  <data key="d7">protein</data>
  <data key="d8">(RefSeq) Fas cell surface death receptor</data>
  <data key="d9">1000.0</data>
  <data key="d10">278.5</data>
  <data key="d11">FAS</data>
</node>
<node id="n6">
  <data key="d0">46|17</data>
  <data key="d1">923|278</data>
  <data key="d2">#BFFFBF</data>
  <data key="d3">FASLG</data>
  <data key="d4">http://www.kegg.jp/dbget-bin/www_bget?hsa:356</data>
  <data key="d12">ENSG00000117560</data>
  <data key="d13">P48023 Q53ZZ1</data>
  <data key="d5">hsa:356</data>
  <data key="d14">356</data>
  <data key="d6">FASLG ALPS1B APT1LG1 APTL CD178 CD95-L CD95L FASL TNFSF6 TNLG1A</data>
  <data key="d7">protein</data>
  <data key="d8">(RefSeq) Fas ligand</data>
  <data key="d9">923.0</data>
  <data key="d10">278.5</data>
  <data key="d11">FASLG</data>
</node>
<node id="n7">
  <data key="d0">46|17</data>
  <data key="d1">1000|249</data>
  <data key="d2">#BFFFBF</data>
  <data key="d3">HLA-</data>
  <data key="d4">http://www.kegg.jp/dbget-bin/www_bget?hsa:3105+hsa:3106+hsa:3107+hsa:3133+hsa:3134+hsa:3135</data>
  <data key="d12">ENSG00000206503,ENSG00000234745,ENSG00000204525,ENSG00000204592,ENSG00000204642,ENSG00000204632</data>
  <data key="d13">P30443 Q5SUL5,P01889 E5FQ95,P10321 Q6R739 Q95HC2,P13747 Q6DU44 O19682 A8K8M6,P30511 Q5JZ47,P17693 Q6DU14</data>
  <data key="d5">hsa:3105,hsa:3106,hsa:3107,hsa:3133,hsa:3134,hsa:3135</data>
  <data key="d14">3105,3106,3107,3133,3134,3135</data>
  <data key="d6">HLA-A HLAA, HLA-B AS B-4901 HLAB, HLA-C D6S204 HLA-JY3 HLAC HLC-C MHC PSORS1, HLA-E HLA-6.2 QA1, HLA-F CDA12 HLA-5.4 HLA-CDA12 HLAF, HLA-G MHC-G</data>
  <data key="d7">protein</data>
  <data key="d8">(RefSeq) major histocompatibility complex class I A,(RefSeq) major histocompatibility complex class I B,(RefSeq) major histocompatibility complex class I C,(RefSeq) major histocompatibility complex class I E,(RefSeq) major histocompatibility complex class I F,(RefSeq) major histocompatibility complex class I G</data>
  <data key="d9">1000.0</data>
  <data key="d10">249.5</data>
  <data key="d11">HLA-</data>
</node>
<node id="n8">
  <data key="d0">46|17</data>
  <data key="d1">923|249</data>
  <data key="d2">#BFFFBF</data>
  <data key="d3">KIR3DL1</data>
  <data key="d4">http://www.kegg.jp/dbget-bin/www_bget?hsa:3802+hsa:3803+hsa:3804+hsa:3811+hsa:3812+hsa:3821+hsa:3824+hsa:57292</data>
  <data key="d12">ENSG00000125498,ENSG00000243772,ENSG00000167633,ENSG00000240403,ENSG00000134545,ENSG00000134539</data>
  <data key="d13">P43626 Q6H2H3 Q6H2H2,P43627 Q8N742 Q6H2H0,P43628 E3NZD8,P43629 Q6H2G3 Q8N6C9,P43630 A0A0U1WNF3 Q8NHK6,P26715,Q13241 Q53ZY6,Q8N109 A0A191URI1</data>
  <data key="d5">hsa:3802,hsa:3803,hsa:3804,hsa:3811,hsa:3812,hsa:3821,hsa:3824,hsa:57292</data>
  <data key="d14">3802,3803,3804,3811,3812,3821,3824,57292</data>
  <data key="d6">KIR2DL1 CD158A KIR-K64 KIR221 NKAT NKAT-1 NKAT1 p58.1, KIR2DL2 CD158B1 CD158b NKAT-6 NKAT6 p58.2, KIR2DL3 CD158B2 CD158b GL183 KIR-023GB KIR-K7b KIR-K7c KIR2DL KIR2DS5 KIRCL23 NKAT NKAT2 NKAT2A NKAT2B p58, KIR3DL1 CD158E1 KIR KIR3DL1/S1 NKAT-3 NKAT3 NKB1 NKB1B, KIR3DL2 3DL2 CD158K KIR-3DL2 NKAT-4 NKAT4 NKAT4B p140, KLRC1 CD159A NKG2 NKG2A, KLRD1 CD94, KIR2DL5A CD158F KIR2DL5 KIR2DL5.1 KIR2DL5.3</data>
  <data key="d7">protein</data>
  <data key="d8">(RefSeq) killer cell immunoglobulin like receptor two Ig domains and long cytoplasmic tail 1,(RefSeq) killer cell immunoglobulin like receptor two Ig domains and long cytoplasmic tail 2,(RefSeq) killer cell immunoglobulin like receptor two Ig domains and long cytoplasmic tail 3,(RefSeq) killer cell immunoglobulin like receptor three Ig domains and long cytoplasmic tail 1,(RefSeq) killer cell immunoglobulin like receptor three Ig domains and long cytoplasmic tail 2,(RefSeq) killer cell lectin like receptor C1,(RefSeq) killer cell lectin like receptor D1,(RefSeq) killer cell immunoglobulin like receptor two Ig domains and long cytoplasmic tail 5A</data>
  <data key="d9">923.0</data>
  <data key="d10">249.5</data>
  <data key="d11">KIR3DL1</data>
</node>
<edge source="n2" target="n1">
  <data key="d15">activation</data>
  <data key="d16">PPrel</data>
  <data key="d17">e0</data>
</edge>
<edge source="n4" target="n3">
  <data key="d15">activation</data>
  <data key="d16">PPrel</data>
  <data key="d17">e1</data>
</edge>
<edge source="n6" target="n5">
  <data key="d15">activation</data>
  <data key="d16">PPrel</data>
  <data key="d17">e2</data>
</edge>
<edge source="n7" target="n8">
  <data key="d15">missing interaction</data>
  <data key="d16">PPrel</data>
  <data key="d17">e3</data>
</edge>
</graph></graphml>